The approval involves the roll-out of a non-cancer chronic pain study for up to 5,000 patients

Updated Date: Mon, 24 Jul 2023 00:00:00 EDT

Updated Date: Mon, 24 Jul 2023 00:00:00 EDT

Updated Date: Mon, 24 Jul 2023 00:00:00 EDT

Updated Date: Mon, 24 Jul 2023 00:00:00 EDT

Updated Date: Mon, 24 Jul 2023 00:00:00 EDT

NHS trusts and integrated care boards have been told by NHS England to review their policies for handling […]

“We know what works,” concludes a report into improving the UK’s national health over the next decade, citing […]

Novel therapy, OK-101, offers a potential way of relieving neuropathic corneal pain

The phase 2 study involves company’s eftilagimod alpha therapy